Spectrum licenses anti-cancer drug Belinostat rights for North America & India from TopoTarget
Thursday, February 04, 2010 10:00 IST Irvine, California
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, announced that it has entered into a co-development and commercialization agreement